© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Viaminate traces its roots back to the energized research atmosphere of the 1960s, when scientists across Europe and Asia sifted through hundreds of retinoid analogs looking for a compound that could enhance vitamin A activity with fewer side effects. They stumbled upon this arylcarboxylic acid derivative, giving birth to a molecule that rapidly sparked interest in liver health studies and chronic disease prevention programs. Over the next decades, pharmaceutical labs tinkered with Viaminate’s backbone, extending research from animal trials to small human studies. Early Japanese patents catapulted production and experimentation, particularly as hepatitis rates surged and doctors looked for alternative therapies that didn’t carry the toxicity profiles of their predecessors.
Viaminate typically comes as a white or off-white crystalline powder, shipped in light-protective containers because the molecule breaks down upon UV exposure. Manufacturing firms often blend it into capsule or tablet formulations, targeting markets in Asia and select regions in Europe where regulatory approval moved more quickly. Each batch gets tested not only for exact content but also for decomposition products, since its breakdown can create reactive intermediates. The focus falls on its distinctive carboxymethyl group, which sets it apart from older retinoic acids and makes it attractive for pharmaceutical design.
This compound weighs in at about 378 grams per mole and features moderate solubility in ethanol and DMSO. Water throws up a barrier; Viaminate’s bulky ring structure keeps it from dissolving well in aqueous buffers, so suspensions get used for in vivo tests. The melting point lands close to 132–136°C, offering a helpful check for identity during incoming quality audits. Labs report strong UV absorption around 315 nm, so stability studies always include careful light management. Chemical stability dips if exposed to basic conditions, prompting storage under mildly acidic pH and low temperatures.
Every pharmaceutical label prints the purity range, typically 98% or above, with tight controls on residual solvents and trace heavy metals. Capsules flag dosing as 50 mg or 100 mg, but the instruction leaflets warn against using the medicine outside liver-related applications. Producers list the compound under its international nonproprietary name, accompanied by the chemical structure, to help busy pharmacists cross-reference it in formularies. Side effect warnings stay front and center, partly to meet compliance standards, but also because dosing errors can amplify vitamin A–like toxicity.
Industrial-scale synthesis relies on arylacetic acid precursors, stepping through condensation reactions before tacking on the signature carboxymethyl fragment using standard coupling chemistry. Most facilities run these steps in jacketed reactors under nitrogen to cut oxidation. The waste stream contains chlorinated organics, demanding careful treatment before disposal. Purification leans on recrystallization, drawing off side products and optimizing yield to maintain cost efficiency for high-volume producers. Some smaller labs still refine with column chromatography for research-grade samples, especially when working in small lots or with labeled isotopes for tracing metabolic fates.
Viaminate’s structure opens doors to creative modification. Chemists graft polar side chains or halogenate specific carbons to alter absorption rates or blunt toxicity. In vitro, oxidants chip away at the aromatic ring, generating metabolites that analysts follow in clinical trial samples. During formulation, the carboxylic acid can form stable salts, improving shelf life and masking bitterness in oral products. Derivatization strategies feed into prodrug work, as some groups chase improved liver cell uptake and reduced off-target distribution. As regulations trend toward precision therapies, chemical engineers reimagine synthesis for greener, cleaner throughput using biocatalytic tools.
Depending on where it lands, Viaminate takes on a local personality. Labels might show “Viaminate calcium,” “Retinylidene dihydrate,” and sometimes one of a dozen branded options aimed at prescription use. Regulatory filings refer to it by IUPAC convention as 2-(5,6,7,8-Tetrahydronaphthalen-2-yl)acetic acid methoxycarbonyloxy. Patent archives turn up code names like CIGA or VI-150. Pharmacies crosscheck against the USP, Ph. Eur., and Japanese Pharmacopoeia listings to avoid mix-ups, especially in busy outpatient clinics serving multiple populations.
Guidance for handling stays strict. Bulk storage demands dry rooms with ambient conditions below 25°C, and spill kits capable of absorbing powder without dispensing particles into shared air. Production teams suit up with gloves, goggles, and respirators — not just for allergy risk but to limit the threat from breakdown products known to irritate skin and lungs. End-use warnings stress not to mix Viaminate with potent oxidizers or store near acids, which can trigger unwanted side reactions. Regulatory authorities, from the FDA to the EMA, maintain regular audits for Good Manufacturing Practice (GMP) compliance, aiming to catch batch deviations before they reach patients.
Doctors look to Viaminate mainly for chronic liver disease, especially early-stage cirrhosis and hepatitis. Some trial data from Japan hints at minor improvements in liver enzyme profiles over months of therapy, with a few researchers branching off into fatty liver disease applications. Beyond pharmaceuticals, a handful of specialty nutritional brands in Asia have used it in fortified capsules, usually marketed with heavy disclaimers and medical supervision only. Researchers investigate it as a retinoid pathway modulator in dermatology, but no approvals exist outside liver use. Animal feed supplements crop up in veterinary settings, though regulators enforce strict residue controls in livestock.
Viaminate research has always bounced between academic curiosity and practical need. The largest body of work surrounds its effect on hepatic fibrosis, with a few collaborative studies branching into anti-inflammatory mechanisms in non-liver tissues. Pharmacologists have spent years piecing together its receptor interactions and off-target effects, sometimes generating hope for cancer chemoprevention — an avenue that hasn’t translated into marketable therapies so far. Newer work focuses on delivery technologies, from nanoparticle encapsulation to slow-release intramuscular depots, with the twin goals of reducing toxicity and boosting adherence for patients with compliance issues. Collaborative consortia in Southeast Asia share data to build a deeper evidence pool, but funding challenges hamper large-scale trials outside single-country studies.
Toxicology teams usually point to the similarity between Viaminate’s side effect profile and those of classic vitamin A analogs: headache, joint pain, and skin flaking top the list. Rat and dog studies from the 1970s showed dose-related liver and kidney lesions at high exposure, poking holes in dreams of unlimited dosing. Follow-up work in humans tracked a narrow therapeutic window, beyond which patients risked teratogenicity and long-term organ strain. Regulators require ongoing post-marketing surveillance and regular reporting of any adverse events tied to accidental ingestion or overdose, especially in pediatric or pregnant populations. The push for data transparency means every clinical site must log and investigate even minor incidents, going so far as to freeze distribution lots for investigation if red flags pop up.
Interest in Viaminate keeps evolving, much like the compound itself. New labs push into synthetic analogs that swap out key groups for better tissue selectivity or lower risk. The field hungers for larger, better-powered studies to clarify its long-term benefit in liver disease, especially given the rise in fatty liver tied to obesity and diabetes trends worldwide. As researchers learn more about retinoid receptors and their broad biological roles, hope lingers that molecular tweaking might yield fresh therapies beyond liver care, from metabolic disorders to dermatology. Advocacy for greener synthetic routes grows louder, as chemical industries move toward sustainable and low-waste manufacturing. Meanwhile, safety disciplines remain on high alert, flagging new metabolites and side effects to regulators and the scientific community. Ultimately, the story of Viaminate mirrors the broader journey of drug development, full of promise, challenge, and the relentless push to balance benefit against risk.
Every time I look at a label in the supplement aisle, I ask myself what’s actually helping my body run better and what’s filler. For products like Viaminate, identifying the key parts of the formula means knowing what you're actually getting. In this case, the main components each play a role, and those roles matter for your wellbeing.
Vitamin A (as Retinol Palmitate): Retinol Palmitate counts as a strong choice for boosting eye health and supporting the immune system. Vitamin A, when supplied in the daily recommended range, helps protect vision, especially for those of us exposed to hours at a screen, and supports skin repair. Most folks don’t get enough fresh greens or orange veggies daily, so a clean source can make a difference.
Vitamin D3 (Cholecalciferol): Cholecalciferol helps the body use calcium, which matters for those worried about bone health down the line. After seeing so many neighbors and friends struggle with brittle bones or slow healing as they age, it’s clear just how much D3 helps the body lay a solid foundation.
Vitamin E (as dl-Alpha Tocopheryl Acetate): This isn't just fancy talk for a health buzzword. Vitamin E guards cells from the oxidative stress. That means less wear and tear from pollution, stress and some processed foods people grab in a hurry. A solid E source in your daily routine isn’t about chasing a trend; it’s about basic self-care in modern living.
Vitamin C (Ascorbic Acid): Think beyond sniffles and colds. Vitamin C helps the body patch itself up, especially after a hard workout, a rough week or even a minor cut. Science shows people who get enough C have fewer problems with their gums and energy levels, not just immune strength.
The B family, especially B1 (Thiamine), B2 (Riboflavin), B3 (Niacinamide), B6 (Pyridoxine), and B12 (Cyanocobalamin), appear across most formulas because of their energy-boosting and nerve-protecting qualities. Anyone who’s dragged themselves through a long workday or juggled a packed family schedule knows the value of mental clarity and steady hands.
Folic Acid, known for its role in pregnancy and newborn health, supports red blood cell production for everyone, not just expecting mothers. A lack of it leaves people feeling drained and foggy.
Calcium Pantothenate (Vitamin B5): This often gets overlooked yet supports metabolism and helps convert food into energy—handy for anyone with a busy lifestyle.
Excipients and Fillers: To hold it all together, manufacturers use compounds like microcrystalline cellulose and magnesium stearate. These ingredients work as carriers and don’t add nutritional value but keep each tablet uniform and shelf-stable.
Understanding the real building blocks inside products like Viaminate goes beyond just scanning for familiar names. Trust comes from transparency, so checking sources, dosages, and the balance of nutrients means you’re not swallowing empty promises. Always look for third-party certifications, and if anything ever seems out of sync with your needs, talk to your healthcare provider for a reality check.
Viaminate isn’t a name you hear every day unless you hang around pharmacists or physicians. It’s a chemically modified form of vitamin A, designed to help the body regulate cell growth and immune system performance. Doctors often use Viaminate to manage chronic skin disorders, especially psoriasis. Pharmaceutical companies started developing it decades ago to create a drug that delivers the benefits of vitamin A without some of its harsher side effects.
Vitamin A keeps skin healthy, plays a part in maintaining eyesight, and keeps the immune system ready for daily challenges. Viaminate, being a derivative, does much of the same heavy lifting but with a twist: it doesn’t build up as much in the liver, reducing the chance of toxicity. People who have dealt with persistent plaque psoriasis sometimes see dramatic changes in redness and scaling after their doctor prescribes Viaminate. Studies from dermatology journals highlight that it leads to clearer skin for many users, often within a few months of prescribed use.
Psoriasis can affect more than just the skin. It gnaws away at confidence, sleep, and overall energy. Viaminate’s role in soothing skin and taming inflammation makes a genuine difference in the quality of life for these patients. Clearer skin generally means less itching and irritation, so there are nights with better sleep and days with fewer distractions from pain. People often mention that their skin hurt less in winter and handled small cuts better once their treatment started.
Pharmaceutical reviews and peer-reviewed research have tracked how patients respond to Viaminate across different populations. The verdict points to measurable improvements in moderate-to-severe skin problems and acceptable tolerability for most adult users. For doctors, the lower risk of liver issues, compared to classic vitamin A compounds, gives an extra touch of safety. Still, patients always need careful monitoring — people with liver problems, high cholesterol, or women planning pregnancy must talk through every detail with their healthcare provider.
It’s worth noting that some people experience dry lips, peeling skin, or mild headaches. This comes with taking many vitamin A-based drugs. Following up with a dermatologist or pharmacist lets users keep side effects in check and keep an open channel for questions.
Skin conditions like psoriasis sometimes get dismissed as cosmetic concerns, but anyone living with stubborn plaque knows it’s much more. People deserve options that move beyond smearing creams or dealing with the drawbacks of steroid pills. Viaminate brings another tool to the table, especially for populations in regions where sunlight, humidity, or genetic history pushes skin problems into chronic territory.
Doctors, pharmacists, and health educators can help spread basic facts about Viaminate so more people can discuss it as a legitimate option. Health ministries and insurance companies can look at real-world data to streamline access for the people who need it most. As with many drugs, lowering hurdles to prescriptions and improving health literacy around medicines leads to greater well-being for communities as a whole.
Doctors have turned to Viaminate, a synthetic retinoid, for managing symptoms linked to chronic eczema, acne and some liver issues. Plenty of people get relief from their symptoms, but not everyone gets a smooth ride from this drug. It’s like most things in medicine—some win, others lose.
When it comes to Viaminate, one thing doctors have noticed is its link to dry skin and mucous membranes. Imagine finishing a brisk walk on a cold day, lips chapped and cheeks flaking—that’s the daily deal for some people on this medication. This side effect can push people to moisturize obsessively, yet sometimes that’s not enough. Nosebleeds sometimes join the party, as the dry nasal passages start to crack. Itchy, scaly skin might bug you from day to night and, in a few cases, cause people to drop out of treatment.
Viaminate might upset your stomach, leading to nausea, diarrhea or stomach pain. These are not rare events. If you’ve ever spent a day doubled over in the bathroom after trying a new medicine, you know the disruption that digestive trouble can bring. Studies have found that some patients end up reducing their dose because the gut impact draws the line; the numbers aren’t massive, but they aren’t tiny either.
Doctors run regular blood tests for anyone taking Viaminate. That’s not paranoia. The liver can take a hit with this drug. Elevated liver enzymes show up often in the lab results—sometimes enough to force a break from treatment. Viaminate can also trigger lipid changes, such as raising cholesterol or triglyceride levels, which nags at the long-term health picture. If you’ve watched someone struggle with cholesterol concerns already, you can picture the sort of anxiety these lab numbers cause.
Viaminate has a red flag for any woman of childbearing age. The science is clear: retinoids like this can damage a developing fetus. Taking the drug while pregnant might lead to birth defects that nobody wants to risk. Women who might become pregnant often face strict contraception rules, frequent pregnancy tests, and heavy counseling about the dangers. This kind of impact goes way beyond the typical prescription and into real-life decision-making territory.
Doctors and patients keep a close eye on symptoms. Sometimes lowering the dose can help keep skin and gut problems under control. Liver tests and blood work remain constant companions during treatment. For women who could get pregnant, solid birth control and honest conversations are non-negotiable. Reporting new symptoms early gives a better shot at stopping complications before they worsen.
Trust between doctor and patient matters. Nobody wants to keep quiet about troubling symptoms, so open conversations help everyone work out what’s next. Pharmacists and nurses offer backup when things get rough. The foundation is current, clear information about the drug, what it can do, and how to handle what it brings along. Every patient scenario runs a little differently, which means there’s no one-size-fits-all answer. But side effects from Viaminate never get ignored.
For those using Viaminate as part of acne or skin disorder treatment, the daily ritual turns into something more than a checklist. Doctors prescribe this vitamin A derivative because it tackles stubborn cases—sometimes where antibiotics and creams just haven’t worked. As someone who has battled acne into adulthood, I remember chasing after quick fixes. The difference only showed up once I stuck to a steady routine, giving the medicine space to work its slow magic. With Viaminate, that means respecting the schedule set by a healthcare provider, usually after a meal so the body absorbs the medicine fully.
Taking Viaminate with a substantial meal does not just prevent an upset stomach; it unlocks its power. A greasy breakfast might sound unappealing to some, but Viaminate binds well with dietary fat, helping it enter your bloodstream. A bowl of oatmeal or toast won’t cut it here. Think more along the lines of eggs, yogurt, or avocado—foods with real fat content. Many patients who forget this step wind up with weaker results. Skipping or rushing breakfast led to less improvement for me until I switched my routine.
The temptation to tweak dosage appears often. I know people who doubled up after missing a pill or quit after a week of dry lips and red cheeks. Yet, Viaminate belongs to a family of medicines that build up in your system. Too much at once can bring on strong side effects. Taking less risks letting the acne come back, sometimes worse than before. The safest call: follow the doctor’s guidance closely and ask questions if something feels off. Regular blood work, which feels tedious, detects any early warning signs in your liver, kidneys, or cholesterol levels.
Peeling lips and itchy cheeks drive people to reconsider Viaminate within the first month. Sensitive skin needs gentle washes, fragrance-free moisturizers, and a stash of lip balm. Wearing sunscreen makes a real difference since this drug increases sun sensitivity. Stubborn headaches or sudden mood changes should always get flagged to a doctor. I found it helpful to jot down changes, even the minor ones, in a notebook to spot patterns before they became problems. Support from family and friends helps too—I leaned on mine when facing the mood swings that sometimes come with retinoids.
Not all bodies respond to Viaminate in the same way. Genetics, age, diet, and medical history all play a role. In my years watching others navigate this medication—from teens to people managing chronic skin problems—the ones who fared best worked in lockstep with their healthcare teams. Open conversations around fears, side effects, and realistic timelines to clear skin kept expectations grounded. It’s rarely a “one and done” drug. Monthly visits let users and doctors make slight adjustments as needed.
Facts matter, but so do lived experiences. Medical research confirms Viaminate’s ability to reduce oil gland size and lower acne count in severe cases. Yet daily life with this drug demands patience and attention to detail. Simple changes—consistent meal timing, honest symptom tracking, clear communication—maximize its benefits. For those searching for clearer skin or relief from persistent breakouts, small habits add up to bigger changes over time.
Viaminate often shows up as an excipient, binder, or additive in food, pharmaceutical, and supplement products. For people who pay close attention to ingredient labels, especially those following vegan or vegetarian diets, the source of additives can be tricky to track down.
Every time I read a long list of ingredients, I think about what goes into the capsule or tablet—not just the main ingredient, but everything that holds it together. Many people, including my own friends who eat plant-based, want to make choices in line with their ethics. A lot of synthetic substances claim to be vegan, but it takes digging to learn if that’s actually true for each stage of production.
Manufacturers usually make excipients like Viaminate from a mix of sources. Plant cellulose and other carbohydrates get used in many modern supplement recipes. Animal sources such as gelatin and lactose sometimes replace these, sometimes out of tradition, and other times because they cut costs or improve texture. Even now, many product labels just say "excipients" or "additives," without details about plant or animal origins.
It often surprises people that even the “vegetarian-friendly” section at health food shops can include animal-based binders or coatings. I have seen supplement manufacturers switch from animal to plant sources after customer feedback, and others resist change because raw material costs go up.
Regulatory agencies such as the FDA in the United States or EFSA in Europe require clarity in ingredient lists. They don’t force companies to state the source unless the ingredient poses an allergy risk or has legal significance, like gluten or dairy. Certification by recognized vegan and vegetarian organizations usually means that someone checked not only the primary ingredient, but also the processing aids. Yet, without these certifications, consumers still have a tough time.
The few companies that openly communicate about their viaminate sourcing tend to use plant material. These companies attract loyal buyers from vegan and vegetarian communities. Lately, more brands have started to mention “vegan-friendly" or “vegetarian capsules” on packaging, but not always for every additive.
Even with a sharp eye, a regular shopper might struggle to confirm whether viaminate fits their own standards. A basic rule I follow: If the product label or brochure doesn't call out plant-based sources, I contact the company. I have also relied on reviews from people in vegan groups who double-check ingredients for the community.
Talk to supplement sellers and ask questions. Look for third-party labels, like The Vegan Society or Vegetarian Society. Reach out to manufacturers for documentation, which thoughtful companies will provide. Stick with brands known for plant-based certifications and check for certifications, not just claims.
Expanding demand for ethical products has sparked more transparent practices. As plant-based diets grow, more brands meet the standards for vegan and vegetarian consumers. Until full transparency becomes standard, asking questions and sharing information keeps everyone better informed.
| Names | |
| Preferred IUPAC name | ethyl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate |
| Other names |
Vitamin A Retinol Palmitate |
| Pronunciation | /vaɪˈæmɪneɪt/ |
| Identifiers | |
| CAS Number | 306-26-9 |
| 3D model (JSmol) | Here is the **3D model (JSmol) string** for the product **Viaminate**: ``` CC1=C(C(CCC1(C)C)NC(=O)C2=CC=CC=C2)C(=O)O ``` This is the **SMILES string** for Viaminate, which can be used in JSmol or other molecular viewers to generate its 3D structure. |
| Beilstein Reference | 2452340 |
| ChEBI | CHEBI:32282 |
| ChEMBL | CHEMBL2104440 |
| ChemSpider | 4444104 |
| DrugBank | DB09221 |
| ECHA InfoCard | echa-info-card-10004546 |
| EC Number | 275-349-6 |
| Gmelin Reference | 293723 |
| KEGG | C07344 |
| MeSH | D014775 |
| PubChem CID | 65706 |
| RTECS number | UM9650000 |
| UNII | 073L3146K3 |
| UN number | 2811 |
| CompTox Dashboard (EPA) | DTXSID2010707 |
| Properties | |
| Chemical formula | C27H33NO6 |
| Molar mass | 458.597 g/mol |
| Appearance | Light yellow tablet |
| Odor | Odorless |
| Density | 1.2 g/cm3 |
| Solubility in water | Insoluble in water |
| log P | 4.62 |
| Acidity (pKa) | 2.75 |
| Basicity (pKb) | 10.85 |
| Magnetic susceptibility (χ) | Magnetic susceptibility (χ) of Viaminate is -62.0 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.5890 |
| Viscosity | 350-450 cSt |
| Dipole moment | 4.82 D |
| Thermochemistry | |
| Std enthalpy of combustion (ΔcH⦵298) | -6135.3 kJ/mol |
| Pharmacology | |
| ATC code | A13AA09 |
| Hazards | |
| Main hazards | May cause damage to organs through prolonged or repeated exposure. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. Read label before use. If medical advice is needed, have product container or label at hand. |
| Autoignition temperature | Autoignition temperature: 400°C |
| Lethal dose or concentration | LD50 (rat, oral): 650 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 1,500 mg/kg |
| NIOSH | VIY000 |
| PEL (Permissible) | PEL: 10 mg/m³ |
| REL (Recommended) | 1 x 1 cap daily |
| Related compounds | |
| Related compounds |
Vitamin A Retinol Retinoic acid Retinal Isotretinoin |
